Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension

Treprostinil, a prostacyclin analogue, is approved for the treatment of pulmonary arterial hypertension (PAH) in adults. Transition from parenteral to oral treprostinil has been successfully accomplished in adults with PAH but not in children. In this multicenter study, pediatric patients treated wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pulm Circ
Main Authors: Ivy, D. Dunbar, Feinstein, Jeffrey A., Yung, Delphine, Mullen, Mary P., Kirkpatrick, Edward C., Hirsch, Russel, Austin, Eric D., Fineman, Jeffrey, Truong, Uyen, Solum, Derek, Deng, C.Q., Hopper, Rachel K.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6628532/
https://ncbi.nlm.nih.gov/pubmed/31215336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019856471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados